The FDA has completed an inspection of Synomics Pharmaceutical Services’ facilities and operations in Wareham, MA. The inspection included both PAI and general regulatory compliance, as Synomics Pharma had been named in three NDAs. No 483’s were issued.     John Pirro, vice president and chief operating officer of Synomics Pharma, said, “The positive inspection of our facilities and operations by the FDA attests to the strength of our comprehensive quality management system....